Alphavalue/DIVACONS | Brandes Investment Partners has taken advantage of the sharp fall in the stock market value of the ...

IBL International has entered a strategic collaboration with healthcare company Grifols to develop biomarker panels for ...

IBL will develop biomarker panels for use with Grifols' random-access, single-molecule counting platform, and the firms will collaborate on testing workflows.

Under this collaboration, IBL will develop biomarker panels for specialty diagnostics based on Grifols’ random access, single ...

IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, today announced a ...

In recent weeks, European markets have experienced significant turbulence, with the pan-European STOXX Europe 600 Index dropping 8.44%, marking its steepest decline in five years amid heightened ...

Brookfield had filed a non-binding offer on Nov. 19 for Grifols that valued the developer of human plasma-based drugs at ...

Donald Trump’s commercial war against the rest of the world arrives with several Ibex 35 companies, the main Spanish stock market indicator, more exposed than ever to the United States.

Pharma and biotech companies are breathing a sigh of relief after the tariffs announced by President Donald Trump Wednesday afternoon excludes pharmaceuticals.